Search

Now showing items 1-2 of 2

Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate

original article

open access

published version

Fiala, Ondřej

;

Hošek, Petr

;

Korunková, Hana

;

Hora, Milan

;

Kolář, Jiří

;

Šorejs, Ondřej

;

Topolčan, Ondřej

;

Filipovský, Jan

;

Liška, Václav

;

Santoni, Matteo

;

Buti, Sebastiano

;

Fínek, Jindřich

2024

Cancer Medicine

13 (1)

BACKGROUND: The introduction of novel hormonal therapies represented by enzalutamide (ENZ) and abiraterone acetate (ABI) has reached a great progress in the treatment of metastatic castration-resistant prostate cancer ...

Giant Cell Temporal Arteritis Followed by Severe Encephalopathy Induced by Immunotherapy in a Patient with Metastatic Renal Cell Carcinoma Achieving Durable Partial Response: A Case Report

casuistics

open access

published version

Fiala, Ondřej

;

Tkadlecová, Michaela

;

Pivovarčíková, Kristýna

;

Baxa, Jan

;

Stránský, Petr

;

Šiková, Dominika

;

Hora, Milan

;

Fínek, Jindřich

2024

Case Reports in Oncology

17 (1)

Introduction: Combined immuno-oncology (IO) regimens are the cornerstone of the current front-line systemic therapy for metastatic renal cell carcinoma (mRCC). Despite the fact that combined IO regimens show high efficacy, ...

Search

Filters

Concomitant antihypertensive medication and outcome of patients with metastatic castration-resistant prostate cancer receiving enzalutamide or abiraterone acetate

original article

open access

published version

Fiala, Ondřej

Hošek, Petr

Korunková, Hana

Hora, Milan

Kolář, Jiří

Šorejs, Ondřej

Topolčan, Ondřej

Filipovský, Jan

Liška, Václav

Santoni, Matteo

Buti, Sebastiano

Fínek, Jindřich

2024

Cancer Medicine

13

(1)

BACKGROUND: The introduction of novel hormonal therapies represented by enzalutamide (ENZ) and abiraterone acetate (ABI) has reached a great progress in the treatment of metastatic castration-resistant prostate cancer ...

Giant Cell Temporal Arteritis Followed by Severe Encephalopathy Induced by Immunotherapy in a Patient with Metastatic Renal Cell Carcinoma Achieving Durable Partial Response: A Case Report

casuistics

open access

published version

Fiala, Ondřej

Tkadlecová, Michaela

Pivovarčíková, Kristýna

Baxa, Jan

Stránský, Petr

Šiková, Dominika

Hora, Milan

Fínek, Jindřich

2024

Case Reports in Oncology

17

(1)

Introduction: Combined immuno-oncology (IO) regimens are the cornerstone of the current front-line systemic therapy for metastatic renal cell carcinoma (mRCC). Despite the fact that combined IO regimens show high efficacy, ...